Extraintestinal pathogenic @entity526 (E. coli) is considered as the main causative agent of urinary @entity281 worldwide. The relationship between antimicrobial resistance, phylogenetic groups, @entity1 characteristics and adhesin virulence genes are complex and not fully understood. In this study, among 146 urinary isolates of @entity526 , phylogenetic groups and various adhesin virulence genes were examined with multiplex Polymerase Chain Reaction methods. @entity1 characteristics divided into sex, @entity2335 and @entity2885 ; community-acquired and hospital-acquired; complicated and @entity281 . Antimicrobial resistance was also determined. The papAH gene was seen more often in @entity2885 than @entity2335 and female than male @entity1 . iha gene was more frequent in hospital-acquired @entity281 than in @entity5046 . sfa/focDE was more frequent in @entity869 , @entity4509 , @entity801 , @entity802 , @entity4258 , @entity2261 , @entity2756 , @entity7048 , @entity3524 , @entity2177 and @entity206 / @entity207 susceptible and extended-spectrum b-lactamase (ESBL) and multi-drug resistance (MDR) negative isolates. focG was seen more often in @entity802 , @entity4258 , @entity2261 , @entity2756 , @entity2177 susceptible and MDR negative isolates. fimH and papAH were more commonly observed in @entity115 / @entity798 and @entity3524 susceptible isolates, respectively. iha and afa/draBC genes were more frequent in resistant isolates than the susceptible ones; for iha, in @entity869 , @entity115 / @entity798 , @entity802 , @entity2261 , @entity2756 resistant and ESBL and MDR positive isolates; for afa/draBC, in @entity3524 , @entity2261 , @entity2177 , @entity206 / @entity207 resistant and ESBL and MDR positive isolates, this trend was observed. ST 131 @entity526 virulence gene pattern has a direct effect on resistance profile. Isolates belong to that clonal group has MDR and commonly harbour afa/draBC and iha genes. Our findings may provide new insights into the relationships between pathogenesis, @entity1 characteristics and resistance of @entity526 UTI.

Relationship between phylogenetic groups, antibiotic resistance and @entity1 characteristics in terms of adhesin genes in XXXX and @entity2885 isolates of @entity526 .

@entity1 :: ('9606', 'Species') :: ['patient', 'Patient', 'patients'] @entity801 :: ('MESH:D005839', 'Chemical') :: ['gentamicin'] @entity2261 :: ('MESH:D002444', 'Chemical') :: ['cefuroxime'] @entity2756 :: ('MESH:D002443', 'Chemical') :: ['ceftriaxone'] @entity7048 :: ('MESH:D002437', 'Chemical') :: ['cefazolin'] @entity4258 :: ('MESH:D009643', 'Chemical') :: ['norfloxacin'] @entity115 :: ('MESH:D000658', 'Chemical') :: ['amoxicillin'] @entity2177 :: ('MESH:D002939', 'Chemical') :: ['ciprofloxacin'] @entity4509 :: ('MESH:D000583', 'Chemical') :: ['amikacin'] @entity798 :: ('MESH:D019818', 'Chemical') :: ['clavulanic acid'] @entity3524 :: ('MESH:D002439', 'Chemical') :: ['cefotaxime'] @entity281 :: ('MESH:D007239', 'Disease') :: ['uncomplicated infection', 'tract infections', 'infections'] @entity802 :: ('MESH:D009268', 'Chemical') :: ['nalidixic acid'] @entity5046 :: ('MESH:D017714', 'Disease') :: ['community-acquired infections'] @entity206 :: ('MESH:D014295', 'Chemical') :: ['trimethoprim'] @entity207 :: ('MESH:D013420', 'Chemical') :: ['sulfamethoxazole'] @entity869 :: ('MESH:D000667', 'Chemical') :: ['ampicillin'] @entity2885 :: ('MESH:D011704', 'Disease') :: ['pyelonephritis'] @entity2335 :: ('MESH:D003556', 'Disease') :: ['cystitis'] @entity526 :: ('562', 'Species') :: ['Escherichia coli', 'E. coli']
@entity2335 :: (MESH:D003556,Disease) :: ['cystitis']
